Physician
Maccumber, Mathew
Maccumber, Mathew was paid $1.14M by Medicaid between Jan 2018 and Nov 2024, across 12 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 66% of everything it billed.
33Billing provider infoMACCUMBER, MATHEW
HARVEY, IL 60426
HARVEY, IL 60426
33aNPI1649270224assigned 07/26/2005
33bProvider typeOphthalmology Physician
28Total paid$1.14M
24GClaims10,996
24DCodes billed12
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Illinois
Rank by total paid#19 of 431
Median peer was paid$34K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,232 | $31K | |
| 2019 | 1,633 | $62K | |
| 2020 | 1,586 | $169K | |
| 2021 | 1,978 | $208K | |
| 2022 | 1,698 | $258K | |
| 2023 | 1,675 | $269K | |
| 2024incomplete | 1,194 | $146K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 66% | 852 | 728 | $752K |
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 1,846 | 1,571 | $240K |
| 92134 | 5.9% | 4,264 | 3,813 | $67K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.0% | 2,060 | 1,914 | $57K |
| 92226 | 1.3% | 934 | 536 | $15K | |
| 92202 | <1% | 808 | 732 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 64 | 55 | $2K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 44 | 39 | $2K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 28 | 27 | $936.61 |
| 92201 | <1% | 56 | 49 | $568.31 | |
| 92225 | <1% | 23 | 12 | $466.91 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 17 | 17 | $186.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.